CONFLICT OF INTEREST
TY TY received honoraria from Sanofi, Mitsubishi Tanabe Pharma, and Kyorin Pharma, and grant support from Sanofi. SU is an advisory board member of GlaxoSmithKline K.K. (GSK), received honoraria for lectures from AstraZeneca K.K. (AZ) GSK and Sanofi, and grant support from AZ, Novartis Pharma K.K., and Maruho Co. Ltd.